StockData
Castle Biosciences Inc logo

Castle Biosciences Inc (CSTL) stock

CSTLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/304% below fair value
$33.38+0.40 (+1.21%)

Close on Nov 18, 2026Market cap $1.02BP/E –Yield 0.00%

Castle Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Castle Biosciences's market cap was $1.04B on Nov 11, 2026, against $1.17B a year earlier. Over the last 5 years it ranged from $366.13M to $1.17B, with a median of $668.62M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.04B-8.6%
2025Dec 31, 2025$1.13B+52.2%
2024Dec 31, 2024$745.56M+28.5%
2023Dec 29, 2023$580.30M-6.4%
2022Dec 30, 2022$620.29M-42.8%
2021Dec 31, 2021$1.08B-18.6%
2020Dec 31, 2020$1.33B+127.1%
2019Dec 31, 2019$586.84M–

More Castle Biosciences figures

See a number that looks wrong?